Goetz Kathleen reported AUPH

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001896369-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 4, 2026

Published

Jun 8, 2026

Ingested by INSIDER

Nov 5, 03:54 UTC

Last re-read

Nov 5, 03:54 UTC

Extracted facts

Filer

Goetz Kathleen

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Aurinia Pharmaceuticals Inc. — Director Stock Option (right to buy)

Ticker

AUPH

Shares

23.9K

Price per share

$0

Execution date (reported)

Jun 4, 2026

Owned after transaction

23.9K shares

Days from execution to publication

4

What this establishes

Goetz Kathleen filed this Form 4 reporting a grant or award of AUPH on Jun 4, 2026. It became public on Jun 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Goetz Kathleencik:0001896369

Issuer

Aurinia Pharmaceuticals Inc.cik:0001600620

Revision history · 0

No field has changed since this record was first ingested.